Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions.

Average daily volume for ADVT is 1 million shares. Today’s news has caused the volume to increase to over 4.9 million shares in the morning hours of trading.

Advantis Corp. Press Release:

NEWPORT BEACH, CA, Oct. 22, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced that is has partnered with former NFL offensive lineman, Kyle Turley, to help market and distribute Amster-Can products. Turley, board member of the Gridiron Greats Assistance Fund, which provides medical and other assistance to retired football players, has been a vocal advocate for cannabis. Turley is also the founder of Neuro XPF, and member of Shango, a Las Vegas based company that holds medical and recreational distribution licenses in Oregon, Washington, and Nevada; they will also soon be fully licensed in California and Michigan.

Advantis has shown a pattern of developing synergistic partnerships, and clearly established this relationship in this same vein. Advantis CEO, Darren Cherry, says this partnership will quickly grow the Amster-Can product line, increase distribution channels, and visibility for the fast-growing company. “We can’t wait to can Mister Turley’s favorite strain, Saint Jack,” Cherry exclaimed. “In addition to canning for his businesses, we will be creating an arrangement to add additional strains to our Amster-Can branded products.” Advantis has previously only provided three strains that were grown by mutual benefit in cooperation with, Natural Elements. As business has expanded, Advantis’ needs have resulted in them seeking out additional partnerships to help fill the surging demand for Amster-Can products.

Last month, Advantis announced a product expansion with Master Win in Northern California; then they announced the edible expansion and branding; with this newest partnership, Advantis will be able to almost immediately expand its distribution channels. “We will now be able to take advantage of the distribution license that Shango has worked diligently to acquire. We round out our product lineup with the highest quality in the marketplace. Most importantly, we can now access additional markets in states that we’re not in yet,” Cherry explained. “We will have more than twelve strains available. Further, we have another partnership in development that will produce a similar synergistic relationship.” Shango is focused on securing licensing in every state where it’s possible too. They are able to navigate the legal and regulatory framework necessary to establish a legal cannabis operation in a given state. “I am very excited to have formed this relationship with Mister Turley. His reputation and advocacy for those in need is admirable and inspires me to do more.”

Kyle Turley played through pain throughout his twenty plus years of playing football. He was diagnosed with CTE, due to suffering over one hundred concussions, was addicted to pain killers, anti-inflammatories, and had suicidal thoughts until 2015, when he discovered the healing and pain-relieving effects of marijuana. “I went cold turkey in 2015,” Turley said. “I would not have my family, my kids, my house, everything I have right now, if not for cannabis.” Turley has spent the past several years advocating for cannabis studies, seeking rule changes regarding how the NFL views cannabis vs. doctor-prescribed opiates, and reaching out to help others that have suffered the pain, CTE, and opiate-addicted cycle that prevails in professional sports. His establishment of Neuro XPF was specifically to help those in professional sports with its patented CBD formula, that Turley has found most effective.

Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.

Links to Advantis pictures and websites can be found on Facebook and Instagram pages, and at advantiscorp.comrosin6.comelixicure.com, and amstercan.com.

About Advantis Corporation

Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  EmergingGrowth.com, or its associates may have a position either long or short in any company mentioned herein. Please read our full disclosure, which can be found here, http://emerginggrowth.com/disclosure/. Please consult an investment professional before investing in anything viewed within this article or any other portion of EmergingGrowth.com. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Add a Comment to this Post

comments